Nobuyuki Okamura Selected Research

florbenazine F 18

1/2012	Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging.
7/2011	In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nobuyuki Okamura Research Topics

Disease

67	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 11/2002
25	Cognitive Dysfunction 10/2022 - 03/2002
20	Dementia (Dementias) 10/2022 - 07/2009
17	Amyloid Plaque 09/2015 - 01/2004
12	Gliosis 10/2022 - 01/2018
9	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2022 - 01/2017
7	Tauopathies 01/2021 - 09/2013
7	Parkinson Disease (Parkinson's Disease) 01/2019 - 09/2009
6	Disease Progression 12/2018 - 06/2014
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 11/2009
5	Sleepiness 01/2019 - 03/2002
4	Corticobasal Degeneration 01/2021 - 09/2013
4	Constipation 01/2019 - 01/2011
4	Atrophy 01/2019 - 05/2014
4	Proteostasis Deficiencies 01/2018 - 11/2009
3	Multiple System Atrophy 01/2022 - 06/2010
3	Parkinsonian Disorders (Parkinsonism) 01/2019 - 05/2004
2	Primary Progressive Aphasia 09/2018 - 01/2018
2	Frontotemporal Dementia (Semantic Dementia) 01/2018 - 05/2014
2	Normal Pressure Hydrocephalus 01/2018 - 09/2015
2	Body Weight (Weight, Body) 03/2017 - 12/2002
2	Amyloidosis 01/2012 - 05/2010
1	Neuroinflammatory Diseases 08/2022
1	Chronic Renal Insufficiency 01/2021
1	Stroke (Strokes) 10/2020
1	REM Sleep Behavior Disorder 01/2019
1	Cerebellar Ataxia (Dysmetria) 01/2019
1	Prodromal Symptoms 01/2019
1	Inflammation (Inflammations) 12/2018
1	Primary Progressive Nonfluent Aphasia (Progressive Nonfluent Aphasia) 01/2018
1	Movement Disorders (Movement Disorder) 01/2017
1	Dysbiosis 01/2016
1	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2014
1	Chronic Traumatic Encephalopathy 06/2014
1	Diabetes Mellitus 01/2013

Drug/Important Bio-Agent (IBA)

44	Amyloid (Amyloid Fibrils)IBA 10/2022 - 01/2004
24	THK5351IBA 08/2022 - 02/2016
15	Biomarkers (Surrogate Marker)IBA 10/2022 - 11/2002
13	Monoamine Oxidase (MAO)IBA 10/2022 - 01/2018
10	tau Proteins (tau Protein)IBA 01/2021 - 11/2005
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2009
7	Amyloid beta-PeptidesIBA 03/2022 - 01/2004
7	Donepezil (Aricept)FDA LinkGeneric 03/2016 - 03/2006
7	BenzoxazolesIBA 11/2014 - 03/2004
7	2- (2- (2- dimethylaminothiazol- 5- yl)ethenyl)- 6- (2- (fluoro)ethoxy)benzoxazoleIBA 08/2013 - 04/2007
5	daiokanzotoIBA 01/2019 - 01/2011
5	Pharmaceutical PreparationsIBA 01/2018 - 03/2002
5	LigandsIBA 01/2017 - 11/2009
4	Histamine Antagonists (Antihistamines)IBA 01/2019 - 12/2010
4	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2019 - 09/2013
4	Histamine (Histamine Dihydrochloride)FDA Link 01/2010 - 03/2006
3	quinolineIBA 10/2022 - 11/2005
3	SynucleinsIBA 01/2019 - 11/2009
3	2- (4- aminophenyl)- 6- (2- fluoroethoxy)quinolineIBA 05/2014 - 04/2011
2	Biological ProductsIBA 01/2022 - 01/2017
2	Loratadine (Alavert)FDA Link 01/2019 - 03/2011
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2018 - 08/2013
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2017 - 12/2002
2	Glucose (Dextrose)FDA LinkGeneric 11/2017 - 12/2002
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 03/2016 - 01/2012
2	Sennosides (Senokot)IBA 01/2016 - 01/2011
2	benzimidazoleIBA 02/2014 - 11/2005
2	florbenazine F 18IBA 01/2012 - 07/2011
2	Cholinergic Agents (Cholinergics)IBA 01/2012 - 04/2008
2	AD 20 (AD-20)IBA 01/2012 - 07/2011
2	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 07/2011 - 02/2010
2	Hypnotics and Sedatives (Sedatives)IBA 07/2011 - 12/2010
2	Chlorpheniramine (Chlorphenamine)FDA LinkGeneric 03/2011 - 03/2002
2	alpha-SynucleinIBA 06/2010 - 09/2009
2	Prion ProteinsIBA 05/2010 - 11/2009
2	6- (2- fluoroethoxy)- 2- (2- (4- methylaminophenil)ethenyl)benzoxazoleIBA 03/2007 - 03/2004
1	IndicanIBA 01/2021
1	EnzymesIBA 01/2021
1	indoleIBA 01/2021
1	desloratadine (Aerius)FDA LinkGeneric 01/2019
1	LaxativesIBA 01/2019
1	Polyvinyl Chloride (PVC)IBA 01/2018
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	ZincIBA 01/2018
1	MetalsIBA 01/2018
1	CopperIBA 01/2018
1	IonsIBA 01/2018
1	Protein AggregatesIBA 01/2018
1	6- ((3- fluoro- 2- hydroxy)propoxy)- 2- (4- methylaminophenyl)quinolineIBA 01/2017
1	ProdrugsIBA 01/2016
1	Cathartics (Purgatives)IBA 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2016
1	GlucosidasesIBA 01/2016
1	rheinIBA 01/2016
1	THK5105IBA 06/2014
1	2- ((4- (4- methylamino)phenyl)- 1,3- butadienyl)benzimidazoleIBA 02/2014
1	BenzothiazolesIBA 09/2013
1	Prealbumin (Transthyretin)IBA 01/2012

Therapy/Procedure

7	Therapeutics 01/2018 - 01/2004
2	Kampo Medicine (Kampo) 01/2011 - 01/2011
1	Cerebrospinal Fluid Shunts 09/2015
1	Myocardial Revascularization 01/2012
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2012